Cresilon

Visit us at the National Conference on EMS, Booth 203, to learn more about TRAUMAGEL? #ems #traumacare

Honoring those who served. Thank you, Veterans. #veteransday

We're excited to be at OhioHealth Trauma Care 2024! TRAUMAGEL’s ability to control moderate to severe bleeding in seconds provides a fast, easy, and efficient solution in critical situations – when time is of the essence. Stop by our booth to learn more about TRAUMAGEL. #traumacare #ems

TOMORROW ?? Cresilon is presenting at Joint Trauma System (JTS) DoD Center of Excellence for Trauma Listen in to hear from Joe Landolina about TRAUMAGEL for controlling moderate to severe bleeding??

Joe Landolina, CEO and co-founder of Cresilon was recently invited to the Dave Crenshaw Success Show!?? Joe shared his inspiring journey from early chemistry experiments with his grandfather to building a cutting-edge medical device company.?? Cresilon developed plant-based hemostatic technology that saved countless pets' lives (VETIGEL?) and is now poised to impact human trauma care. ? Joe emphasized transparency, mentorship, and collaboration as key principles in his success. Listen to the podcast here:?https://lnkd.in/e3uRzCr4 #biotechnology #medicaldevice #innovation

Since we announced the FDA 510(k) clearance for TRAUMAGEL?, we have been featured in the news around the U.S., highlighting this milestone. This FDA clearance sets the foundation for transforming the standard of care in emergency and military medicine, addressing the 91% of potentially survivable battlefield deaths caused by uncontrolled bleeding.* We want to thank everyone who has supported us on this journey and we are excited to see what is next for TRAUMAGEL?. There is much more to come! Stay tuned for more updates and head to cresilon.com to learn more about TRAUMAGEL?. *Source: Eastridge BJ, Mabry RL, Seguin P, et al. “Death on the battlefield (2001–2011): implications for the future of combat casualty care.” #innovation #lifesciences #biotechnology

Visit us at ICMM booth 46 and learn about TRAUMAGEL? capabilities. #military #lifesciences #innovations

Excited to announce that Cresilon has been selected to exhibit TRAUMAGEL? at the Vizient Innovative Technology Exchange! TRAUMAGEL? is set to transform emergency medicine by controlling moderate to severe bleeding in seconds.? ? Honored to be part of this event and to showcase how TRAUMAGEL? can improve patient outcomes in critical care situations. Click on the link below to learn more. _ Vizient, Inc #Healthcare #Innovation #biotech

As a proud New York-based company, we reflect on the courage shown on 9/11 and remain committed to supporting those who protect and serve.

TRAUMAGEL? is a hemostatic gel designed to control moderate to severe bleeding in seconds. Visit us at AAST booth 417 to learn more! #traumacare #traumasurgeon #biotechnology